Research discovery

Find the original research

Live search across PubMed, the U.S. National Library of Medicine's citation database, and ClinicalTrials.gov. We show what each record is and link you to it; we don't summarise findings or rank studies by what they conclude.

Published studies · PubMed Clinical trials · ClinicalTrials.gov

Find the original research

Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (opens ClinicalTrials.gov)

A Study Comparing the Efficacy and Safety of HRS9531 Injection With Semaglutide Injection in Subjects With Obesity (opens ClinicalTrials.gov)

Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes (opens ClinicalTrials.gov)

The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure (opens ClinicalTrials.gov)

Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range (opens ClinicalTrials.gov)

A Ph2 Study to Evaluate the Safety, Efficacy and Tolerability of HT-6184 and Semaglutide in Obese Participants With T2DM (opens ClinicalTrials.gov)

GLP-1 RA for Stage 1 Type 1 Diabetes (opens ClinicalTrials.gov)

Effect of a Low-carbohydrate Diet on Weight Loss in People Using the Injectable GLP-1 Agonist Semaglutide for Weight Loss (opens ClinicalTrials.gov)

Incretin Microdosing for Cardiometabolic Health in People With HIV (opens ClinicalTrials.gov)

A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2) (opens ClinicalTrials.gov)

Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss. (opens ClinicalTrials.gov)

A Research Study to Understand How People With Type 2 Diabetes Take Ozempic® and if the Ozempic®App Helps Them Stay on This Treatment (opens ClinicalTrials.gov)

SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial (opens ClinicalTrials.gov)

Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function (opens ClinicalTrials.gov)

Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis (opens ClinicalTrials.gov)

Impact of Semaglutide Withdrawal on Cardiometabolic Profile and Physiology of Energy Balance: Recovery Effects After Semaglutide Termination (opens ClinicalTrials.gov)

Semaglutide PrIor to CathEeter Ablation in Patients With Atrial Fibrillation (opens ClinicalTrials.gov)

A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial) (opens ClinicalTrials.gov)

GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight (opens ClinicalTrials.gov)

Reversal to Normoglycemia by Treating Prediabetes (opens ClinicalTrials.gov)